Caviunin scaffold containing drug - Central Drug Research Institute
Latest Information Update: 15 Feb 2022
At a glance
- Originator Central Drug Research Institute
- Developer Aveta Biomics; Central Drug Research Institute
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Bone disorders